News RSS Bioethics News.

08/08/2017

CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player

External Link - Source: Science

MilliporeSigma, a subsidiary of pharmaceutical giant Merck KGaA of Darmstadt, Germany, has become a new major player in the complicated European patent battles over CRISPR, the revolutionary genome-editing tool.

This entry was posted in Genetics, Pharmaceuticals and tagged , . Bookmark the permalink.